000			02018 a2200577 4500
005			20250515193811.0
264		0	_c20100817
008			201008s 0 0 eng d
022			_a1569-8041
024	7		_a10.1093/annonc/mdp521 _2doi
040			_aNLM _beng _cNLM
100	1		_aGlimelius, B
245	0	0	_aA window of opportunity phase II study of enzastaurin in chemonaive patients with asymptomatic metastatic colorectal cancer. _h[electronic resource]
260			_bAnnals of oncology : official journal of the European Society for Medical Oncology _cMay 2010
300			_a1020-6 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAdenocarcinoma _xdrug therapy
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aCarcinoembryonic Antigen _xblood
650	0	4	_aColorectal Neoplasms _xdrug therapy
650	0	4	_aDisease-Free Survival
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aIndoles _xtherapeutic use
650	0	4	_aL-Lactate Dehydrogenase _xblood
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Recurrence, Local _xdrug therapy
650	0	4	_aPrognosis
650	0	4	_aProtein Kinase C _xantagonists & inhibitors
650	0	4	_aProtein Kinase C beta
650	0	4	_aTissue Distribution
700	1		_aLahn, M
700	1		_aGawande, S
700	1		_aCleverly, A
700	1		_aDarstein, C
700	1		_aMusib, L
700	1		_aLiu, Y
700	1		_aSpindler, K L
700	1		_aFrödin, J-E
700	1		_aBerglund, A
700	1		_aByström, P
700	1		_aQvortrup, C
700	1		_aJakobsen, A
700	1		_aPfeiffer, P
773	0		_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 21 _gno. 5 _gp. 1020-6
856	4	0	_uhttps://doi.org/10.1093/annonc/mdp521 _zAvailable from publisher's website
999			_c19288268 _d19288268